Colgate-Palmolive Company Company Profile (NYSE:CL)

Colgate-Palmolive Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive Company announced a quarterly dividend on Tuesday, September 26th. Stockholders of record on Monday, October 23rd will be paid a dividend of $0.40 per share on Wednesday, November 15th. This represents a $1.60 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Friday, October 20th. View Colgate-Palmolive Company's Dividend History.

Colgate-Palmolive Company (NYSE:CL) released its earnings results on Thursday, July, 28th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.69 by $0.01. The company earned $3.85 billion during the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive Company had a return on equity of 3,121.95% and a net margin of 15.83%. The firm's quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.70 earnings per share. View Colgate-Palmolive Company's Earnings History.

Colgate-Palmolive Company is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Colgate-Palmolive Company.

16 brokers have issued twelve-month price objectives for Colgate-Palmolive Company's stock. Their predictions range from $68.00 to $85.00. On average, they anticipate Colgate-Palmolive Company's share price to reach $76.38 in the next year. View Analyst Ratings for Colgate-Palmolive Company.

Here are some recent quotes from research analysts about Colgate-Palmolive Company stock:

• 1. According to Zacks Investment Research, "Colgate has outperformed the industry in the past month. We remain encouraged by the progress on its 2012 Restructuring Program and expect additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view. Moreover, the company has been infamous among investors with its meet or beat earnings track record. However, the company’s sales missed expectations for the fifth straight quarter in second-quarter due to continued softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Nevertheless, the company remains focused on four fundamentals to boost profits including, increased spending on advertisements; innovation across portfolio; higher spends on e-commerce business and aggressively maximizing productivity. Also, its disciplined capital strategy bodes well. Estimates have been stable lately." (10/17/2017)
• 2. Morgan Stanley analysts commented, "Our new $84 PT is based on ~24.5x times our upwardly revised FY19 EPS estimate (~23xex a 7.5% strategic halo), representing a ~20% return with a ~2% dividend yield," the firm said."Furthermore, we see a 2:1 ratio of bull case upside relative to bear case downside." (9/25/2017)
• 3. Jefferies Group LLC analysts commented, "Late Tues. (5/16), the NY Post reported that CL Chair/CEO Ian Cook recently told investors he would consider selling the company for $100/share (~19.5x EV/EBITDA). While we have no knowledge of any potential M&A or the specific accuracy of this report, this strikes us as a reasonable price (for both a potential buyer and for CL as sellers). We view JNJ as the most likely acquirer, followed by ULVR and KHC/3G. Valuation remains nearly full, reit. $76 PT, Hold. CL CEO/Chairman Ian Cook reportedly would consider selling for $100/share: Late Tuesday, the NY Post reported the Ian Cook, Colgate’s Chairman and CEO, recently signaled he would be open to selling the company… for $100/share", while at a meeting with institutional investors. The Post further noted recent speculation the CL is being stalked by" Unilever and pointed to activist Nelson Peltz’s stake in P&G as a potential spark for sector consolidation." (5/17/2017)

Some companies that are related to Colgate-Palmolive Company include Unilever plc (ULVR), Reckitt Benckiser Group Plc (RB), Estee Lauder Companies, Inc. (The) (EL), Herbalife LTD. (HLF), Energizer Holdings (EPC), Nu Skin Enterprises (NUS), Matthews International Corporation (MATW), USANA Health Sciences (USNA), PZ Cussons plc (PZC), Revlon (REV), Avon Products (AVP), Nautilus Group, Inc. (The) (NLS), KP Tissue (KPT), Swallowfield plc (SWL), Blackmores Limited (BKL), DS Healthcare Group (DSKX), L'Oreal SA (OR) and Litebulb Group Ltd (LBB).

Colgate-Palmolive Company's management team includes the folowing people:

• Ian M. Cook, Chairman of the Board, President, Chief Executive Officer
• Daniel B. Marsili, Chief Human Resource Officer
• John J. Huston, Senior Vice President - Chief of Staff
• Patricia Verduin Ph.D., Chief Technology Officer
• Mukul V. Deoras, Chief Marketing Officer
• Henning I. Jakobsen, Vice President, Corporate Controller
• Victoria L. Dolan, Chief Transformation Officer
• Delia H. Thompson, Chief Investor Relations Officer
• Makarand Karnataki, Company Secretary and Compliance Officer
• Jennifer M. Daniels, Chief Legal Officer and Secretary

Colgate-Palmolive Company's stock is owned by many different of institutional and retail investors. Top institutional shareholders include APG Asset Management N.V. (0.46%), Robeco Institutional Asset Management B.V. (0.08%), PGGM Investments (0.06%), Shell Asset Management Co. (0.04%), State Treasurer State of Michigan (0.03%) and Fisher Asset Management LLC (0.03%). Company insiders that own Colgate-Palmolive Company stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was sold by a variety of institutional investors in the last quarter, including State Treasurer State of Michigan, PGGM Investments, Private Asset Management Inc., Douglas Lane & Associates LLC, Carnick & Kubik Group LLC, Bridges Investment Counsel Inc., Oakbrook Investments LLC and Neville Rodie & Shaw Inc.. Company insiders that have sold Colgate-Palmolive Company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Patricia Verduin, Richard J Kogan and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Shell Asset Management Co., Assenagon Asset Management S.A., Pensionfund DSM Netherlands, Pensionfund Sabic, Quantitative Systematic Strategies LLC, Robeco Institutional Asset Management B.V. and FormulaFolio Investments LLC. View Insider Buying and Selling for Colgate-Palmolive Company.

Shares of Colgate-Palmolive Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Colgate-Palmolive Company stock can currently be purchased for approximately $72.32.